Neuroblastoma Drugs Market, By Route of Administration (Oral and Injectable), By Type, By End-user, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2025-2034
REPORT HIGHLIGHT
Neuroblastoma Drugs Market size was valued at USD 815.5 Million in 2023, expanding at a CAGR of 5.80% from 2024 to 2032.
The most prevalent kind of cancer among newborns is neuroblastoma. The sympathetic nervous system\'s embryonic malignancy, which arises from the neuroblasts, is what causes the cancer. The malignancy spreads to the spinal cord, chest, or adrenal nerve tissues. Neuroblastoma is diagnosed before the age of five in over 90% of cases. In rare instances, prenatal ultrasounds may reveal the malignancy. The increased incidence of neuroblastoma and childhood cancer are the main causes of the neuroblastoma drug market\'s expansion. According to estimates, as of 2023, over 700 children in the US will receive a neuroblastoma diagnosis annually. Additionally, the neuroblastoma drugs market is expected to develop as a result of people\'s increased awareness of cancer diagnosis and treatment. In the upcoming years, it is anticipated that the growing number of incident instances that are age- and gender-specific will spur industry expansion.
Neuroblastoma Drugs Market- Market Dynamics
Rising Incidence of Neuroblastoma
One of the main driver driving the market expansion for neuroblastoma drugs is the rise in the disease\'s occurrence. Neuroblastoma diagnoses have increased noticeably in recent years, especially in juvenile populations. The need for sophisticated and successful therapeutic strategies has increased as a result of this incidence trend. Pharmaceutical firms and researchers are encouraged to step up their efforts in creating novel neuroblastoma medications as more cases are discovered due to enhanced diagnostic capabilities and more awareness, which supports the neuroblastoma drug market\'s expansion.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL NEUROBLASTOMA DRUGS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
Y-mabs Therapeutics, Inc.
Bristol-Myers Squibb Company
MacroGenics Inc.
AstraZeneca plc
Eli Lilly and Company
Recordati Group
Cellectar Biosciences, Inc.
Teva Pharmaceutical Industries Ltd.
Pfizer Inc.
United Therapeutics Corporation
Others
GLOBAL NEUROBLASTOMA DRUGS MARKET, BY ROUTE OF ADMINISTRATION- MARKET ANALYSIS, 2019 - 2032
Oral
Injectable
GLOBAL NEUROBLASTOMA DRUGS MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032
Chemotherapy
Immunotherapy
Bone Marrow Transplantation
Retinoid therapy
Surgery
Others
GLOBAL NEUROBLASTOMA DRUGS MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032
Hospitals
Homecare
Speciality Clinics
Other
GLOBAL NEUROBLASTOMA DRUGS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- The U.S.
- Canada
Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Neuroblastoma Drugs Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Neuroblastoma Drugs Market Snippet by Route of Administration
2.1.2. Neuroblastoma Drugs Market Snippet by Type
2.1.3. Neuroblastoma Drugs Market Snippet by End-user
2.1.4. Neuroblastoma Drugs Market Snippet by Country
2.1.5. Neuroblastoma Drugs Market Snippet by Region
2.2. Competitive Insights
3. Neuroblastoma Drugs Key Market Trends
3.1. Neuroblastoma Drugs Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Neuroblastoma Drugs Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Neuroblastoma Drugs Market Opportunities
3.4. Neuroblastoma Drugs Market Future Trends
4. Neuroblastoma Drugs Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Neuroblastoma Drugs Market: COVID-19 Impact Analysis
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. Neuroblastoma Drugs Market Landscape
6.1. Neuroblastoma Drugs Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Neuroblastoma Drugs Market – By Route of Administration
7.1. Overview
7.1.1. Segment Share Analysis, By Route of Administration, 2023 & 2032 (%)
7.1.2. Oral
7.1.3. Injectable
8. Neuroblastoma Drugs Market – By Type
8.1. Overview
8.1.1. Segment Share Analysis, By Type, 2023 & 2032 (%)
8.1.2. Chemotherapy
8.1.3. Immunotherapy
8.1.4. Bone Marrow Transplantation
8.1.5. Retinoid therapy
8.1.6. Surgery
8.1.7. Others
9. Neuroblastoma Drugs Market – By End-user
9.1. Overview
9.1.1. Segment Share Analysis, By End-user, 2023 & 2032 (%)
9.1.2. Hospitals
9.1.3. Homecare
9.1.4. Speciality Clinics
9.1.5. Others
10. Neuroblastoma Drugs Market– By Geography
10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
10.2. North America
10.2.1. Overview
10.2.2. Neuroblastoma Drugs Key Manufacturers in North America
10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.2.4. North America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
10.2.5. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.2.6. North America Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.2.7. U.S.
10.2.7.1. Overview
10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.7.3. U.S. Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
10.2.7.4. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.2.7.5. U.S. Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.2.8. Canada
10.2.8.1. Overview
10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.8.3. Canada Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
10.2.8.4. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.2.8.5. Canada Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.3. Europe
10.3.1. Overview
10.3.2. Neuroblastoma Drugs Key Manufacturers in Europe
10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.3.4. Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
10.3.5. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.3.6. Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.3.7. Germany
10.3.7.1. Overview
10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.7.3. Germany Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
10.3.7.4. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.3.7.5. Germany Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.3.8. France
10.3.8.1. Overview
10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.8.3. France Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
10.3.8.4. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.3.8.5. France Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.3.9. Italy
10.3.9.1. Overview
10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.9.3. Italy Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
10.3.9.4. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.3.9.5. Italy Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.3.10. Spain
10.3.10.1. Overview
10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.10.3. United Kingdom Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
10.3.10.4. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.3.10.5. United Kingdom Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.3.11. United Kingdom
10.3.11.1. Overview
10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.11.3. United Kingdom Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
10.3.11.4. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.3.11.5. United Kingdom Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.3.12. Russia
10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.12.2. Russia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
10.3.12.3. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.3.12.4. Russia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.3.13. Netherlands
10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.13.2. Netherlands Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
10.3.13.3. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.3.13.4. Netherlands Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.3.14. Sweden
10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.14.2. Sweden Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
10.3.14.3. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.3.14.4. Sweden Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.3.15. Poland
10.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.15.2. Poland Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
10.3.15.3. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.3.15.4. Poland Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.3.16. Rest of Europe
10.3.16.1. Overview
10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.16.3. Rest of the Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
10.3.16.4. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.3.16.5. Rest of the Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.4. Asia Pacific (APAC)
10.4.1. Overview
10.4.2. Neuroblastoma Drugs Key Manufacturers in Asia Pacific
10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.4.4. Asia Pacific Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
10.4.5. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.4.6. Asia Pacific Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.4.7. India
10.4.7.1. Overview
10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.7.3. India Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
10.4.7.4. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.4.7.5. India Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.4.8. China
10.4.8.1. Overview
10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.8.3. China Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
10.4.8.4. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.4.8.5. China Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.4.9. South Korea
10.4.9.1. Overview
10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.9.3. South Korea Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
10.4.9.4. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.4.9.5. South Korea Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.4.10. Japan
10.4.10.1. Overview
10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.10.3. Japan Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
10.4.10.4. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.4.10.5. Japan Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.4.11. Australia
10.4.11.1. Overview
10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.11.3. Australia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
10.4.11.4. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.4.11.5. Australia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.4.12. Thailand
10.4.12.1. Overview
10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.12.3. Thailand Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
10.4.12.4. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.4.12.5. Thailand Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.4.13. Indonesia
10.4.13.1. Overview
10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.13.3. Indonesia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
10.4.13.4. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.4.13.5. Indonesia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.4.14. Philippines
10.4.14.1. Overview
10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.14.3. Philippines Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
10.4.14.4. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.4.14.5. Philippines Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.4.15. Rest of APAC
10.4.15.1. Overview
10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.15.3. Rest of APAC Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
10.4.15.4. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.4.15.5. Rest of APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.5. Latin America
10.5.1. Overview
10.5.2. Neuroblastoma Drugs Key Manufacturers in Latin America
10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.5.4. Latin America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
10.5.5. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.5.6. Latin America Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.5.7. Brazil
10.5.7.1. Overview
10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.7.3. Brazil Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
10.5.7.4. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.5.7.5. Brazil Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.5.8. Mexico
10.5.8.1. Overview
10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.8.3. Mexico Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
10.5.8.4. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.5.8.5. Mexico Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.5.9. Argentina
10.5.9.1. Overview
10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.9.3. Argentina Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
10.5.9.4. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.5.9.5. Argentina Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.5.10. Colombia
10.5.10.1. Overview
10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.10.3. Colombia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
10.5.10.4. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.5.10.5. Colombia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.5.11. Rest of LATAM
10.5.11.1. Overview
10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.11.3. Rest of LATAM Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
10.5.11.4. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.5.11.5. Rest of LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.6. Middle East and Africa
10.6.1. Overview
10.6.2. Neuroblastoma Drugs Key Manufacturers in Middle East and Africa
10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.6.4. Middle East and Africa Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
10.6.5. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.6.6. Middle East and Africa Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.6.7. Saudi Arabia
10.6.7.1. Overview
10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.7.3. Saudi Arabia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
10.6.7.4. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.6.7.5. Saudi Arabia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.6.8. United Arab Emirates
10.6.8.1. Overview
10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.8.3. United Arab Emirates Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
10.6.8.4. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.6.8.5. United Arab Emirates Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.6.9. Israel
10.6.9.1. Overview
10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.9.3. Israel Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
10.6.9.4. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.6.9.5. Israel Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.6.10. Turkey
10.6.10.1. Overview
10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.10.3. Turkey Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
10.6.10.4. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.6.10.5. Turkey Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.6.11. Algeria
10.6.11.1. Overview
10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.11.3. Algeria Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
10.6.11.4. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.6.11.5. Algeria Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.6.12. Egypt
10.6.12.1. Overview
10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.12.3. Egypt Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
10.6.12.4. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.6.12.5. Egypt Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.6.13. Rest of MEA
10.6.13.1. Overview
10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.13.3. Rest of MEA Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
10.6.13.4. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.6.13.5. Rest of MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11. Key Vendor Analysis- Neuroblastoma Drugs Industry
11.1. Competitive Dashboard
11.2. Company Profiles
11.2.1. Y-mabs Therapeutics, Inc.
11.2.2. Bristol-Myers Squibb Company
11.2.3. MacroGenics Inc.
11.2.4. AstraZeneca plc
11.2.5. Eli Lilly and Company
11.2.6. Recordati Group
11.2.7. Cellectar Biosciences, Inc.
11.2.8. Teva Pharmaceutical Industries Ltd.
11.2.9. Pfizer Inc.
11.2.10. United Therapeutics Corporation
11.2.11. Others
12. 360 Degree Analyst View
13. Appendix
13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us
